Pfizer and BioNTech submit application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/logo/pfizer.png)
Bayer supports demining in Ukraine with donation to non-profit "Fondation suisse de déminage"
- Details
- Category: Bayer
![Bayer Bayer](/images/logo/bayer.png)
Pfizer announces positive top-line results from Phase 3 study of 20-valent pneumococcal conjugate vaccine in infants
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/logo/pfizer.png)
Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
- Details
- Category: Roche
![Roche Roche](/images/logo/roche.png)
Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare hematology
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/logo/pfizer.png)
Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
- Details
- Category: Roche
![Roche Roche](/images/logo/roche.png)
Bayer Consumer Health leaders propose new principles for science-led self-care
- Details
- Category: Bayer
![Bayer Bayer](/images/logo/bayer.png)
More Pharma News ...
- GSK signs agreement to support pandemic preparedness in Europe
- Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate based on enhanced spike protein design
- AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager
- Pfizer and BioNTech complete submission to European Medicines Agency for Omicron BA.1 adapted bivalent vaccine candidate
- Bayer to sell men's health product Nebido™ to Grünenthal
- Lilly will supply an additional 150,000 doses of bebtelovimab to U.S. government
- Sanofi Global Health launches nonprofit Impact® brand for 30 medicines in low-income countries